In HER2-positive breast cancer, ISH analysis shows that circCDYL in tumor tissues is elevated nearly 1.63 times compared to adjacent HER+BC tissues, and HER2 gene does not guide circCDYL expression in HER2 cells (Liang et al., 2021). Here, ERBB2 is linked to breast cancer.